# US 2025/0154527 A1 · Promoter for the expression of genes in particular egr2-positive cells in layer 2/3 of mouse cortex

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154527 A1
- Document ID: US20250154527A1
- Status: Published application
- Kind: A1
- Application number: 18/729,674
- Filed: 2023-01-17
- Published: 2025-05-15
- Earliest claimed: 2022-01-19
- Assignees: Friedrich Miescher Institute for Biomedical Research
- Applicants: Friedrich Miescher Institute for Biomedical Research
- Inventors: Georg KELLER; Hassana OYIBO
- Web page: https://patentgrep.com/patent/US20250154527A1

## CPC

- C12N 15/85: for animal cells
- C12N 15/86: Viral vectors
- C07K 14/215: from Halobacteriaceae (F)
- C07K 14/405: from algae
- C07K 14/47: from mammals
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N 2830/008: cell type or tissue specific enhancer/promoter combination
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides an isolated nucleic acid molecule comprising, or consisting of, the nucleic acid sequence of SEQ ID NO:1, or of a nucleic acid sequence of at least 700 bp having at least 80% identity to said sequence of SEQ ID NO:1, wherein said isolated nucleic acid molecule leads to the specific expression in layer 2/3 of mouse cortex of an exogenous gene in a particular population of EGR2-positive cells when a nucleic acid sequence coding for said exogenous gene is operatively linked to said isolated nucleic acid molecule, said particular population of EGR2-positive cells being characterized in that it also expresses ACTA2, ADORA3 and MYH11.

## Claims

### Claim 1

An isolated nucleic acid molecule comprising, or consisting of, the nucleic acid sequence of SEQ ID NO:1, or of a nucleic acid sequence of at least 700 bp having at least 80% identity to said sequence of SEQ ID NO:1, wherein said isolated nucleic acid molecule leads to the specific expression in layer 2/3 of mouse cortex of an exogenous gene in a particular population of EGR2-positive cells when a nucleic acid sequence coding for said exogenous gene is operatively linked to said isolated nucleic acid molecule, said particular population of EGR2-positive cells being characterized in that it also expresses ACTA2, ADORA3 and MYH11.

### Claim 2 (depends on 1)

The isolated nucleic acid molecule of claim 1, further comprising a minimal promoter, e.g. the minimal promoter of SEQ ID NO:2.

### Claim 3 (depends on 1)

An expression cassette comprising, as an element promoting gene expression in specific cells, the isolated nucleic acid according to claim 1, wherein said isolated nucleic acid is operatively linked to at least a nucleic acid sequence encoding for a gene to be expressed specifically in the particular population of EGR2-positive.

### Claim 4 (depends on 3)

A vector comprising the expression cassette of claim 3.

### Claim 5 (depends on 4)

The vector of claim 4, wherein said vector is a viral vector.

### Claim 6

(canceled)

### Claim 7 (depends on 3)

A method of expressing an exogeneous gene comprising the steps of transfecting an isolated cell, a cell line or a cell population with the expression cassette according to claim 3.

### Claim 8 (depends on 3)

An isolated cell comprising the expression cassette of claim 3.

### Claim 9 (depends on 8)

The cell of claim 8 wherein the expression cassette or vector is stably integrated into the genome of said cell.

### Claim 10 (depends on 1)

The isolated nucleic acid molecule of claim 1, wherein the product of the exogenous gene is a light-sensitive molecule, for instance halorhodopsin or channelrhodopsin.

### Claim 11 (depends on 1)

A kit for expressing an exogenous gene comprising the isolated nucleic acid molecule according to claim 1.

### Claim 12 (depends on 2)

An expression cassette comprising, as an element promoting gene expression in specific cells, the isolated nucleic acid according to claim 2, wherein said isolated nucleic acid is operatively linked to at least a nucleic acid sequence encoding for a gene to be expressed specifically in the particular population of EGR2-positive.

### Claim 13 (depends on 4)

An isolated cell comprising the vector of claim 4.

### Claim 14 (depends on 2)

The isolated nucleic acid molecule of claim 2, wherein the product of the exogenous gene is a light-sensitive molecule, for instance halorhodopsin or channelrhodopsin.

### Claim 15 (depends on 3)

The expression cassette of claim 3, wherein the product of the exogenous gene is a light-sensitive molecule, for instance halorhodopsin or channelrhodopsin.

### Claim 16 (depends on 4)

The vector of claim 4, wherein the product of the exogenous gene is a light-sensitive molecule, for instance halorhodopsin or channelrhodopsin.

### Claim 17 (depends on 7)

The method of claim 7, wherein the product of the exogenous gene is a light-sensitive molecule, for instance halorhodopsin or channelrhodopsin.

### Claim 18 (depends on 8)

The cell of claim 8, wherein the product of the exogenous gene is a light-sensitive molecule, for instance halorhodopsin or channelrhodopsin.

### Claim 19 (depends on 2)

A kit for expressing an exogenous gene comprising the isolated nucleic acid molecule according to claim 2.
